Brief: Burning Rock Provides An Update On 2022 Revenue Guidance
18/01/2023 01:38
Jan 17 (Reuters) - Burning Rock Biotech Ltd BNR.O :
* BURNING ROCK PROVIDES AN UPDATE ON 2022 REVENUE GUIDANCE
* EXPECTS COMPANY'S FULL-YEAR REVENUE GROWTH FOR 2022 TO BE
APPROXIMATELY 10%
* EXPECTS ITS REVENUES FOR Q4 OF 2022 TO DROP SINGLE DIGIT
Source text for Eikon: ID:nGNX3fdB1z
Further company coverage: BNR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Burning Rock Biotech
See all newsBurning Rock Biotech's Q2 revenue falls, net loss widens on central laboratory weakness
China's Burning Rock Biotech Q1 revenue falls on lower test volumes
China's Burning Rock Biotech Q4 net loss narrows as costs fall
Cancer diagnostics firm Burning Rock Biotech's Q3 revenue rises on pharma R&D growth
Brief: Burning Rock's Oncoguide™ Oncoscreen™ Plus CDX System Now Approved In Japan As A Companion Diagnostic For Capivasertib In Breast Cancer